Availability of Three Draft Toxicological Profiles, 45896 [C1-2024-09662]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 45896 Federal Register / Vol. 89, No. 102 / Friday, May 24, 2024 / Notices • High Performance Computing (HPC) 0043, by either of the methods listed below. CDC does not accept comments Thomas Santucci, by email. Director, Division of IT Modernization, Office • Federal eRulemaking Portal: of Technology Policy, Office of Governmenthttps://www.regulations.gov. Follow the wide Policy, General Services Administration. instructions for submitting comments. [FR Doc. 2024–11436 Filed 5–23–24; 8:45 am] • Mail: Ms. Stephanie Thomas, ACIP BILLING CODE 6820–68–P Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia DEPARTMENT OF HEALTH AND 30329–4027. Attn: Docket No. CDC– HUMAN SERVICES 2024–0043. Instructions: All submissions received Agency for Toxic Substances and must include the Agency name and Disease Registry docket number. All relevant comments received in conformance with the [Docket No. ATSDR–2024–0001] https://www.regulations.gov suitability Availability of Three Draft policy will be posted without change to Toxicological Profiles https://www.regulations.gov, including any personal information provided. For Correction access to the docket to read background In notice document 2024–09662, documents or comments received, go to appearing on pages 36820 through https://www.regulations.gov. 36821 in the issue of Friday, May 3, The meeting will be webcast live via 2024, make the following correction: the World Wide Web. The webcast link On page 36820, in the first column, in can be found on the ACIP website at the DATES section, on the second line, https://www.cdc.gov/vaccines/acip/ ‘‘May 3, 2024’’ should read ‘‘August 1, index.html. 2024’’. FOR FURTHER INFORMATION CONTACT: [FR Doc. C1–2024–09662 Filed 5–23–24; 8:45 am] Stephanie Thomas, Committee BILLING CODE 0099–10–D Management Specialist, Advisory Committee on Immunization Practices, National Center for Immunization and DEPARTMENT OF HEALTH AND Respiratory Diseases, Centers for HUMAN SERVICES Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Centers for Disease Control and Atlanta, Georgia 30329–4027. Prevention Telephone: (404) 639–8836; Email: [Docket No. CDC–2024–0043] ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: Meeting of the Advisory Committee on Purpose: The Advisory Committee on Immunization Practices Immunization Practices (ACIP) is AGENCY: Centers for Disease Control and charged with advising the Director, Prevention (CDC), Department of Health Centers for Disease Control and Prevention (CDC), on the use of and Human Services (HHS). ACTION: Notice and request for comment. immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is SUMMARY: In accordance with the mandated to establish and periodically Federal Advisory Committee Act, the review and, as appropriate, revise the Centers for Disease Control and list of vaccines for administration to Prevention (CDC) announces the vaccine-eligible children through the following meeting of the Advisory Vaccines for Children program, along Committee on Immunization Practices with schedules regarding dosing (ACIP). This meeting is open to the interval, dosage, and contraindications public. Time will be available for public to administration of vaccines. Further, comment. under applicable provisions of the DATES: The meeting will be held on June Affordable Care Act and Section 2713 of 26, 2024, from 8 a.m. to 5:10 p.m., EDT, the Public Health Service Act, June 27, 2024, from 8 a.m. to 5:15 p.m., immunization recommendations of EDT, and June 28, 2024, from 8:30 a.m. ACIP that have been approved by the to 12 p.m., EDT (times subject to Director, CDC, and appear on CDC change); see the ACIP website for immunization schedules generally must updates: https://www.cdc.gov/vaccines/ be covered by applicable health plans. acip/). Matters to be Considered: The agenda Written comments must be received will include discussions on influenza between June 3–17, 2024. vaccines, chikungunya vaccine, COVID– 19 vaccines, pneumococcal vaccines, ADDRESSES: You may submit comments, meningococcal vaccines, Human identified by Docket No. CDC–2024– VerDate Sep<11>2014 17:40 May 23, 2024 Jkt 262001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 papillomavirus (HPV) vaccines, Respiratory Syncytial Virus (RSV) vaccines for adults, RSV vaccines for maternal and pediatric populations, a combined diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate, and hepatitis B vaccine (Vaxelis®), and dengue vaccine. Recommendation votes are scheduled for influenza vaccines, COVID–19 vaccines, pneumococcal vaccine, Vaxelis®, and RSV vaccines for adults. A Vaccines for Children (VFC) vote is scheduled for Vaxelis®. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda, visit https:// www.cdc.gov/vaccines/acip/meetings/ index.html. Meeting Information: The meeting will be webcast live via the World Wide Web. For more information on ACIP, please visit the ACIP website: https:// www.cdc.gov/vaccines/acip/. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near-duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. Written Public Comment: The docket will be opened to receive written comments on June 3–17, 2024. Written comments must be received by June 17, 2024. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes, including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the E:\FR\FM\24MYN1.SGM 24MYN1


[Federal Register Volume 89, Number 102 (Friday, May 24, 2024)]
[Page 45896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C1-2024-09662]



Agency for Toxic Substances and Disease Registry

[Docket No. ATSDR-2024-0001]

Availability of Three Draft Toxicological Profiles


    In notice document 2024-09662, appearing on pages 36820 through 
36821 in the issue of Friday, May 3, 2024, make the following 
    On page 36820, in the first column, in the DATES section, on the 
second line, ``May 3, 2024'' should read ``August 1, 2024''.

[FR Doc. C1-2024-09662 Filed 5-23-24; 8:45 am]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.